<DOC>
	<DOCNO>NCT02129179</DOCNO>
	<brief_summary>This study aim assess effect glucagon-like peptide-1 cardiac output transpulmonary gradient patient undergo right heart catheterisation clinical reason .</brief_summary>
	<brief_title>The Effect Glucagon-Like Peptide-1 ( GLP-1 ) Pulmonary Vascular Resistance ( PVR ) Patients With Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>Age 18 Able give inform consent On wait list heart transplant Left Ventricular Dysfunction await catheterisation Nicorandil , glibenclamide , Dipeptidyl Peptidase4 inhibitor , GlucagonLike Peptide1 receptor agonist insulin Women child bear age breast feed woman Cardiac pacemaker implant metallic device Unable give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>